Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Nathan Comeaux"'
Autor:
Mehmet Altan, Nathan Comeaux, Joe Y. Chang, Dawei Chen, Chad Tang, Adi Diab, Percy Lee, George R. Blumenschein, Maria E. Cabanillas, Mylene T. Truong, Renata Ferrarotto, Quynh-Nhu Nguyen, Baohua Sun, Saumil Gandhi, Brett W. Carter, Maria Angelica Cortez, Roshal R. Patel, David S. Hong, Vivek Verma, Kewen He, Stephen G. Chun, Shalin J. Shah, James W. Welsh, John V. Heymach, Jeremy J. Erasmus, Frank V. Fossella, Ying Yuan, Michael A. Davies, Edwin R. Parra, Hampartsoum B. Barsoumian, Duygu Sezen, Isabella C. Glitza, Matthew S. Ning
Publikováno v:
Radiotherapy and Oncology. 162:60-67
To report early findings from a phase II trial of high-dose radiotherapy (HD-RT) with or without low-dose RT (LD-RT) for metastatic cancer.Eligible patients had metastatic disease that progressed on immunotherapy within 6 months. Patients were given
Autor:
Nahum Puebla-Osorio, Hampartsaum Barsoumian, Quynh Nhu Nguyen, Pervin Hurmuz, Dawei Chen, Irwin I. Tendler, Nathan Comeaux, Joe Y. Chang, Chad Tang, Vivek Verma, Chike O. Abana, James W. Welsh, Duygu Sezen, Matthew S. Ning, Kewen He
Publikováno v:
Seminars in radiation oncology. 31(3)
Metastatic cancer is inherently heterogeneous, and patients with metastatic disease can experience vastly different oncologic outcomes depending on several patient- and disease-specific characteristics. Designing trials for such a diverse population
Autor:
Ferdinandos Skoulidis, George R. Simon, Idris Bahce, Paul Baas, Joachim G.J.V. Aerts, Quynh Nhu Nguyen, Anna Larissa N. Niemeijer, Steven H. Lin, Dawei Chen, Kewen He, Heike Peulen, Brian P. Hobbs, Roshal R. Patel, Vivek Verma, James W. Welsh, Willemijn S. M. E. Theelen, Joe Y. Chang, John V. Heymach, Patricia M. de Groot, Nathan Comeaux
Publikováno v:
The Lancet Respiratory Medicine, 9(5), 467-475. Elsevier Limited
The Lancet Respiratory Medicine, 9(5), 467-475. Elsevier Ltd.
Theelen, W S M E, Chen, D, Verma, V, Hobbs, B P, Peulen, H M U, Aerts, J G J V, Bahce, I, Niemeijer, A L N, Chang, J Y, de Groot, P M, Nguyen, Q-N, Comeaux, N I, Simon, G R, Skoulidis, F, Lin, S H, He, K, Patel, R, Heymach, J, Baas, P & Welsh, J W 2021, ' Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials ', The Lancet Respiratory Medicine, vol. 9, no. 5, pp. 467-475 . https://doi.org/10.1016/S2213-2600(20)30391-X
The Lancet Respiratory Medicine, 9(5), 467-475. ELSEVIER SCI LTD
The Lancet Respiratory Medicine, 9(5), 467-475. Elsevier Ltd.
Theelen, W S M E, Chen, D, Verma, V, Hobbs, B P, Peulen, H M U, Aerts, J G J V, Bahce, I, Niemeijer, A L N, Chang, J Y, de Groot, P M, Nguyen, Q-N, Comeaux, N I, Simon, G R, Skoulidis, F, Lin, S H, He, K, Patel, R, Heymach, J, Baas, P & Welsh, J W 2021, ' Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials ', The Lancet Respiratory Medicine, vol. 9, no. 5, pp. 467-475 . https://doi.org/10.1016/S2213-2600(20)30391-X
The Lancet Respiratory Medicine, 9(5), 467-475. ELSEVIER SCI LTD
Findings Overall, 148 patients were included in the pooled analysis, 76 of whom had been assigned pembrolizumab and 72 who had been assigned pembrolizumab plus radiotherapy. Median follow-up for all patients was 33 months (IQR 32?4?33?6). 124 (84%) o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcdadd3a2e31d7df46de6d2585dcdbe9
https://research.vumc.nl/en/publications/56927a12-23a7-4f97-a281-de8001690bb8
https://research.vumc.nl/en/publications/56927a12-23a7-4f97-a281-de8001690bb8
Autor:
Quynh-Nhu Nguyen, Nathan Comeaux, S. Gandhi, John V. Heymach, Frank V. Fossella, Percy Lee, George R. Blumenschein, Chad Tang, Adi Diab, James W. Welsh, David S. Hong, Kewen He, J.Y. Chang, Stephen G. Chun, Isabella C. Glitza, Matthew S. Ning
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e471-e472
Purpose/objective(s) Retrospective and prospective studies in patients with oligometastatic non-small-cell lung cancer (NSCLC) suggested clinical benefit after complete metastatic ablation (CMA). So far, no studies have addressed the toxicity and eff
Autor:
Bonnie S. Glisson, Joe Y. Chang, Vassiliki A. Papadimitrakopoulou, John V. Heymach, Katherine Klein, George R. Simon, Vivek Verma, James W. Welsh, Roshal R. Patel, Jianjun Zhang, Ferdinandos Skoulidis, Chunxiao Guo, Taylor R. Cushman, Quynh Nhu Nguyen, Mehmet Altan, Tugce Ozgen, Hari Menon, Girish S. Shroff, Lauren Averett Byers, Dawei Chen, Nathan Comeaux, Chad Tang, Melenda Jeter, Kenneth R. Hess
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 15(12)
Introduction Few advancements in treating limited-stage SCLC (LS-SCLC) have been made in decades. We report here a phase 1/2 trial of concurrent chemoradiotherapy (CRT) and pembrolizumab. Methods This single-center, open-label phase 1/2 study recruit
Autor:
Dawei Chen, Quynh-Nhu Nguyen, S. Gandhi, Chad Tang, Adi Diab, Percy Lee, Hampartsoum B. Barsoumian, Kewen He, John V. Heymach, Nathan Comeaux, Frank V. Fossella, David S. Hong, James W. Welsh, M.A. Davies, George R. Blumenschein, J.Y. Chang, Roshal R. Patel, Isabella C. Glitza, Matthew S. Ning, Stephen G. Chun
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:S118
PURPOSE/OBJECTIVE(S) To report updated findings from a prospective phase II trial of salvage high-dose radiotherapy (HD-RT) with or without low-dose RT (LD-RT) for metastatic cancer (NCT02710253). MATERIALS/METHODS Eligible patients had metastatic di
Autor:
Isabella C. Glitza, Q.N. Nguyen, David S. Hong, Vivek Verma, J.Y. Chang, M.A. Davies, Chad Tang, Adi Diab, Chunxiao Guo, Nathan Comeaux, Roshal R. Patel, Stephen G. Chun, Mehmet Altan, J.W. Welsh, George R. Simon, Hampartsoum B. Barsoumian
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e120-e121
Autor:
Mehmet Altan, Chunxiao Guo, Hampartsoum B. Barsoumian, J.W. Welsh, David S. Hong, Isabella C. Glitza, Nathan Comeaux, Stephen G. Chun, Q.N. Nguyen, George R. Simon, Vivek Verma, Chad Tang, Adi Diab, Roshal R. Patel, M.A. Davies, J.Y. Chang
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:S185
Autor:
Mauricio S. Caetano, Hampartsoum B. Barsoumian, Adi Diab, Jonathan E. Schoenhals, Maria Angelica Cortez, Isabella C. Glitza, Stephen G. Chun, Taylor R. Cushman, Hari Menon, Ailin Li, Fatemeh Masrorpour, Timothy P. Reilly, Ahmed I. Younes, Alexandra P. Cadena, Renata Ferrarotto, David S. Hong, James W. Welsh, Rishab Ramapriyan, Dawei Chen, Nathan Comeaux, Quynh-Nhu Nguyen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundDespite some successes with checkpoint inhibitors for treating cancer, most patients remain refractory to treatment, possibly due to the inhibitory nature of the tumor stroma that impedes the function and entry of effector cells. We devised
Autor:
John V. Heymach, Steven H. Lin, Joe Y. Chang, Paul Baas, Ferdinandos Skoulidis, Willemijn S. M. E. Theelen, Vivek Verma, James W. Welsh, Nathan Comeaux, Dawei Chen
Publikováno v:
Journal of Clinical Oncology. 38:9548-9548
9548 Background: In metastatic non-small cell lung cancer (mNSCLC), the clinical trials NCT02492568 and NCT02444741 are the only known randomized comparisons of pembrolizumab alone versus pembrolizumab combined with radiation therapy (RT). When the t